These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15871863)

  • 1. Is homocysteine important as risk factor for coronary heart disease?
    Cesari M; Rossi GP; Sticchi D; Pessina AC
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):140-7. PubMed ID: 15871863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hyperhomocysteinemia.
    Herrmann W
    Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
    Herrmann W; Lorenzl S; Obeid R
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases?
    Lazzerini PE; Capecchi PL; Selvi E; Lorenzini S; Bisogno S; Galeazzi M; Laghi Pasini F
    Lupus; 2007; 16(11):852-62. PubMed ID: 17971357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperhomocysteinemia. A new coronary risk factor].
    Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
    Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia: a new risk factor for degenerative diseases.
    Herrmann W; Knapp JP
    Clin Lab; 2002; 48(9-10):471-81. PubMed ID: 12389706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
    Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS
    Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine: an emerging age-related cardiovascular risk factor.
    Moustapha A; Robinson K
    Geriatrics; 1999 Apr; 54(4):41, 44-6, 49-51. PubMed ID: 10212627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia in pediatric and young adult renal transplant recipients.
    Belson A; Sanchez J; Alexander SR; Salvatierra O; Dar MH; Reif S; Yorgin PD
    Pediatr Transplant; 2004 Apr; 8(2):161-6. PubMed ID: 15049796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering treatment in coronary heart disease.
    Cesari M; Rossi GP; Pessina AC
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):289-95. PubMed ID: 16250860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
    Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S
    J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?
    Petramala L; Acca M; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2009; 32(4 Suppl):10-4. PubMed ID: 19724160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.